Package 72888-074-14

Brand: oxcarbazepine

Generic: oxcarbazepine
NDC Package

Package Facts

Identity

Package NDC 72888-074-14
Digits Only 7288807414
Product NDC 72888-074
Product ID 72888-074_4844e056-6c56-1482-e063-6394a90a018e
Description

1 BOTTLE in 1 CARTON (72888-074-14) / 250 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2024-02-14
Brand oxcarbazepine
Generic oxcarbazepine
Sample Package No

Linked Drug Pages (1)

OXCARBAZEPINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4844e056-6c56-1482-e063-6394a90a018e", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0372888074146"], "unii": ["VZI5B1W380"], "rxcui": ["283536"], "spl_set_id": ["4ef6a941-a017-40f2-a50a-ab66c43b3347"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Advagen Pharma Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (72888-074-14)  / 250 mL in 1 BOTTLE", "package_ndc": "72888-074-14", "marketing_start_date": "20240214"}], "brand_name": "OXCARBAZEPINE", "product_id": "72888-074_4844e056-6c56-1482-e063-6394a90a018e", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72888-074", "generic_name": "OXCARBAZEPINE", "labeler_name": "Advagen Pharma Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/5mL"}], "application_number": "ANDA215726", "marketing_category": "ANDA", "marketing_start_date": "20220831", "listing_expiration_date": "20271231"}